Simplex Trading
WVE icon

Simplex Trading’s Wave Life Sciences WVE Stock Holding History

Simplex Trading’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$647K Buy
89,263
+68,137
+323% +$888K ﹤0.01% 2969
2025
Q4 		$359K Buy
21,126
+19,920
+1,652% +$202K ﹤0.01% 3634
2025
Q3 		$8K Sell
1,206
-45,024
-97% -$364K ﹤0.01% 8066
2025
Q2 		$300K Buy
46,230
+34,716
+302% +$229K ﹤0.01% 4068
2025
Q1 		$93K Buy
11,514
+10,185
+766% +$111K ﹤0.01% 5128
2024
Q4 		$16K Sell
1,329
-19,316
-94% -$258K ﹤0.01% 6876
2024
Q3 		$169K Buy
20,645
+8,434
+69% +$50.4K ﹤0.01% 4693
2024
Q2 		$60K Buy
12,211
+190
+2% +$1.08K ﹤0.01% 5900
2024
Q1 		$74K Buy
+12,021
New +$60.2K ﹤0.01% 5907
2023
Q4 		– Sell
-4,003
Closed -$21.4K – 9974
2023
Q3 		$23K Buy
4,003
+2,660
+198% +$12.1K ﹤0.01% 6518
2023
Q2 		$4K Sell
1,343
-17,759
-93% -$71.7K ﹤0.01% 8112
2023
Q1 		$82K Buy
19,102
+18,477
+2,956% +$84.7K ﹤0.01% 5391
2022
Q4 		$4K Buy
+625
New +$2.88K ﹤0.01% 8279
2022
Q2 		– Sell
-8
Closed -$15 – 11252
2022
Q1 		$0 Sell
8
-2,828
-100% -$6.93K ﹤0.01% 11522
2021
Q4 		$8K Buy
+2,836
New +$11.8K ﹤0.01% 9236
2021
Q2 		– Sell
-19,471
Closed -$127K – 10799
2021
Q1 		$109K Buy
19,471
+7,648
+65% +$73.5K ﹤0.01% 5630
2020
Q4 		$93K Buy
11,823
+8,109
+218% +$68.1K ﹤0.01% 5518
2020
Q3 		$31K Sell
3,714
-20,066
-84% -$220K ﹤0.01% 6053
2020
Q2 		$247K Buy
23,780
+3,117
+15% +$29.3K ﹤0.01% 3766
2020
Q1 		$193K Sell
20,663
-14,059
-40% -$120K ﹤0.01% 3637
2019
Q4 		$278K Buy
34,722
+30,920
+813% +$758K ﹤0.01% 3384
2019
Q3 		$78K Sell
3,802
-2,075
-35% -$47.6K ﹤0.01% 4587
2019
Q2 		$153K Buy
5,877
+3,229
+122% +$90.5K ﹤0.01% 3747
2019
Q1 		$102K Buy
+2,648
New +$107K ﹤0.01% 4314

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Simplex Trading's WVE Position: Q1 2026 in Review

Simplex Trading increased its Wave Life Sciences (WVE) stake by 323% in Q1 2026, buying an estimated $888K and bringing the position to 89,263 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Simplex Trading first reported a position in WVE in Q1 2019 and has held it in 24 quarters since. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Simplex Trading held 89,263 shares of Wave Life Sciences worth $647K as of Q1 2026.
  • Simplex Trading bought 68,137 Wave Life Sciences shares in Q1 2026, an estimated $888K.
  • Wave Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2969 holding.
  • Simplex Trading first reported a position in Wave Life Sciences in Q1 2019 and has held it in 24 quarters since.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.